Oracle stock's next big AI opportunity may have nothing to do with data centres

Impact · against what's priced in

The AstraZeneca partnership is a marginal positive for Oracle as it provides a concrete path toward the higher-margin software revenue the market currently doubts can offset AI infrastructure costs. For AstraZeneca, the collaboration offers operational efficiencies in trial recruitment with limited immediate financial impact.

ORCL+0.15: Challenges what's priced in
The price assumes

Oracle stock's next big AI opportunity may have nothing to do with data centres

What matters in this story

Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation

Oracle stock's next big AI opportunity may have nothing to do with data centres

What matters in this story

Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation

How each ticker is affected

Connected tickers

Track these names every morning.

Recce Pharmaceuticals advances Phase 3 diabetic foot infection trial to independent data review

Microsoft vs. Oracle: Which Tech Stock Is a Better Buy in 2026?

Kaplan Fox Encourages Innventure, Inc. (INV) Investors with Significant Losses to Contact the Firm Before October 27, 2026

Cisco's president said he used personal AI agents to screen $9,000 worth of his yearly subscriptions

Oracle stock's next big AI opportunity may have nothing to do with data centres

What matters in this story

Next reads from the same story arc

Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation

Oracle stock's next big AI opportunity may have nothing to do with data centres

What matters in this story

Next reads from the same story arc

Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation

How each ticker is affected

Connected tickers

Track these names every morning.

Recce Pharmaceuticals advances Phase 3 diabetic foot infection trial to independent data review

Microsoft vs. Oracle: Which Tech Stock Is a Better Buy in 2026?

Kaplan Fox Encourages Innventure, Inc. (INV) Investors with Significant Losses to Contact the Firm Before October 27, 2026

Cisco's president said he used personal AI agents to screen $9,000 worth of his yearly subscriptions